Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization

被引:31
作者
Dijkstra, F. [1 ]
Riphagen-Dalhuisen, J. [1 ,2 ]
Wijers, N. [1 ]
Hak, E. [2 ]
van der Sande, M. A. B. [1 ,3 ]
Morroy, G. [4 ]
Schneeberger, P. M. [1 ,5 ]
Schimmer, B. [1 ]
Notermans, D. W. [1 ]
van der Hoek, W. [1 ]
机构
[1] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[3] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[4] GGD Hart voot Brabant Municipal Hlth Serv Hart v, Shertogenbosch, Netherlands
[5] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands
关键词
Antibiotics; Coxiella; Q fever; IN-VITRO SUSCEPTIBILITY; COXIELLA-BURNETII; FLUOROQUINOLONES; MOXIFLOXACIN; DOXYCYCLINE; PNEUMONIA;
D O I
10.1017/S0950268810002621
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Data about the effectiveness of different antibiotic regimens for the treatment of acute Q fever from clinical studies is scarce. We analysed the antibiotic treatment regimens of acute Q fever patients in 2007 and 2008 in The Netherlands and assessed whether hospitalization after a minimum of 2 days antibiotic therapy was related to the initial antibiotic therapy. Clinical data on antibiotic treatment and risk factors of acute Q fever patients were obtained from general practitioner medical records and self-reported by patients. For the 438 study patients, doxycycline was the most commonly prescribed initial antibiotic in both study years. After adjustments for confounding factors, doxycycline (200 mg/day), moxifloxacin, as well as other possibly effective antibiotics [including other new fluoroquinolones and doxycycline (100 mg/day)] showed significant lower risks for hospitalization compared to beta-lactam antibiotics and azithromycin (reference group), with the lowest risk for doxycycline (200 mg/day) (odds ratio 0.04, 95% confidence interval 0.01-0.22). These data support current guidelines that recommend doxycycline as the first choice antibiotic for treating acute Q fever.
引用
收藏
页码:1332 / 1341
页数:10
相关论文
共 16 条
[1]   In vitro susceptibility to tetracycline and fluoroquinolones of Japanese isolates of Coxiella burnetii [J].
Andoh, M ;
Naganawa, T ;
Yamaguchi, T ;
Fukushi, H ;
Hirai, K .
MICROBIOLOGY AND IMMUNOLOGY, 2004, 48 (09) :661-664
[2]   Measurement of the antibiotic susceptibility of Coxiella burnetii using real time PCR [J].
Boulos, A ;
Rolain, JM ;
Maurin, M ;
Raoult, D .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (02) :169-174
[3]   Managing Q fever during pregnancy: The benefits of long-term cotrimoxazole therapy [J].
Carcopino, Xavier ;
Raoult, Didier ;
Bretelle, Florence ;
Boubli, Leon ;
Stein, Andreas .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (05) :548-555
[4]   Newer macrolides as empiric treatment for acute Q fever infection [J].
Gikas, A ;
Kofteridis, DP ;
Manios, A ;
Pediaditis, J ;
Tselentis, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3644-3646
[5]   In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin [J].
Gikas, A ;
Spyridaki, I ;
Scoulica, E ;
Psaroulaki, A ;
Tselentis, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) :3276-3278
[6]   Cure of Q fever pneumonia with moxifloxacin: Case report [J].
Kuzman, I ;
Puljiz, I ;
Dakovic-Rode, O .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2005, 37 (10) :778-780
[7]   In vitro susceptibility of Coxiella burnetti to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones [J].
Lever, MS ;
Bewley, KR ;
Dowsett, B ;
Lloyd, G .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (02) :194-196
[8]   Q fever [J].
Maurin, M ;
Raoult, D .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (04) :518-+
[9]   Short report: Q fever pneumonia: Are clarithromycin and moxifloxacin alternative treatments only? [J].
Morovic, N .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (05) :947-948
[10]  
Nabuurs-Franssen M.H., 2008, NED TIJDSCHR MED MIC, V16, P20